XML 49 R34.htm IDEA: XBRL DOCUMENT v3.22.1
Shareholders' Equity (Tables)
12 Months Ended
Dec. 31, 2021
Stockholders' Equity Note [Abstract]  
Schedule of assumptions used in estimation of grant date fair value of RSUs
 
2017
2020
Expected dividend yield
2.68%
0%
Schedule of assumptions used in estimation of grant date fair value of options
 
Average Risk-free interest rate (a)
1.58 %
Expected dividend yield
2.42 %
Average expected volatility (b)
47.90 %

Termination rate

9 %

Suboptimal factor (c)
3.32
 
(a)
Risk-free interest rate represents risk free US$ zero-coupon US Government Bonds at time of grant.
(b)
Expected average volatility represents a weighted average standard deviation rate for the price of the Company’s ordinary shares on the NASDAQ National Market.
(c)
Suboptimal factor represents the multiple of the increase in the market share price on the day of grant of the option which, should it come to pass, will lead to exercise of the option by the employee. It is the average suboptimal factor of the Company and similar companies.
 
Average Risk-free interest rate (a)
2.35 %
Expected dividend yield
2.42%
Average expected volatility (b)
43.71 %

Termination rate

9 %

Suboptimal factor (c)
3.28
 
(a)
Risk-free interest rate represents risk free US$ zero-coupon US Government Bonds at time of grant.
(b)
Expected average volatility represents a weighted average standard deviation rate for the price of the Company’s ordinary shares on the NASDAQ National Market.
(c)
Suboptimal factor represents the multiple of the increase in the market share price on the day of grant of the option which, should it come to pass, will lead to exercise of the option by the employee. It is the average suboptimal factor of the Company and similar companies.
Average Risk-free interest rate (a)
2.92 %
Expected dividend yield
0.0 %
Average expected volatility (b)
45.13 %

Termination rate

9 %

Suboptimal factor (c)
3.2
 
(a)
Risk-free interest rate represents risk free US$ zero-coupon US Government Bonds at time of grant.
(b)
Expected average volatility represents a weighted average standard deviation rate for the price of the Company’s ordinary shares on the NASDAQ National Market.
(c)
Suboptimal factor represents the multiple of the increase in the market share price on the day of grant of the option which, should it come to pass, will lead to exercise of the option by the employee. It is the average suboptimal factor of the Company and similar companies.
Average Risk-free interest rate (a)
2.55 %
Expected dividend yield
0.0 %
Average expected volatility (b)
44.62 %

Termination rate

9 %

Suboptimal factor (c)
3.18
 
(a)
Risk-free interest rate represents risk free US$ zero-coupon US Government Bonds at time of grant.
(b)
Expected average volatility represents a weighted average standard deviation rate for the price of the Company’s ordinary shares on the NASDAQ National Market.
(c)
Suboptimal factor represents the multiple of the increase in the market share price on the day of grant of the option which, should it come to pass, will lead to exercise of the option by the employee. It is the average suboptimal factor of the Company and similar companies.
Average Risk-free interest rate (a)
0.75 %
Expected dividend yield
0.0 %
Average expected volatility (b)
45.29 %

Termination rate

9 %

Suboptimal factor (c)
3.16
 
(a)
Risk-free interest rate represents risk free US$ zero-coupon US Government Bonds at time of grant.
(b)
Expected average volatility represents a weighted average standard deviation rate for the price of the Company’s ordinary shares on the NASDAQ National Market.
(c)
Suboptimal factor represents the multiple of the increase in the market share price on the day of grant of the option which, should it come to pass, will lead to exercise of the option by the employee. It is the average suboptimal factor of the Company and similar companies.
Average Risk-free interest rate (a)
1.41 %
Expected dividend yield
0.0 %
Average expected volatility (b)
45.28 %

Termination rate

9 %

Suboptimal factor (c)
3.14
 
(a)
Risk-free interest rate represents risk free US$ zero-coupon US Government Bonds at time of grant.
(b)
Expected average volatility represents a weighted average standard deviation rate for the price of the Company’s ordinary shares on the NASDAQ National Market.
(c)
Suboptimal factor represents the multiple of the increase in the market share price on the day of grant of the option which, should it come to pass, will lead to exercise of the option by the employee. It is the average suboptimal factor of the Company and similar companies.
Stock Option Summary
 
 
Options outstanding
 
Options exercisable
 
 
 
 
 
 
 
Weighted average
 
 
 
 
 
Weighted average
 
 
 
 
 
 
 
remaining
 
 
 
 
 
remaining
 
Exercise price
 
 
Number
 
 
contractual life
 
 
Number
 
 
contractual life
 
US$
 
 
of options
 
 
(in years)
 
 
of options
 
 
(in years)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
26.91
 
 
 
18,329
 
 
 
1.6
 
 
 
18,329
 
 
 
1.6
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
33.27
 
 
 
14,865
 
 
 
4.3
 
 
 
14,865
 
 
 
4.3
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
28.38
 
 
 
35,533
 
 
 
2.4
 
 
 
35,533
 
 
 
2.4
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
39.62
 
 
 
76,176
 
 
 
3.1
 
 
 
76,176
 
 
 
3.1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
36.11
 
 
 
83,016
 
 
 
4.3
 
 
 
83,016
 
 
 
4.3
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
33.83
 
 
 
87,334
 
 
 
5.1
 
 
 
87,334
 
 
 
5.1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

32.54

 

   

134,343

     

6.4

      -       -  
                                   

41.84

     

129,925

     

7.4

      -       -  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
579,521
 
 
 
 
 
 
 
315,253
 
 
 
 
 
Stock Option Activity
 
 
Number
of options
 
 
Weighted
average
exercise price
 
 
Weighted
average
grant date
fair value
 
 
 
 
 
 
US$
 
 
US$
 
 
 
 
 
 
 
 
 
 
 
Balance at January 1, 2019
 
 
365,495
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Granted
 
 
141,928
 
 
 
33.83
 
 
 
13.35
 
Exercised
 
 
(5,500
)
 
 
28.09
 
 
 
10.03
 
Forfeited
 
 
(36,676
)
 
 
35.88
 
 
 
13.50
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance at December 31, 2019
 
 
465,247
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Granted
 
 
148,426
 
 
 
32.54
 
 
 
14.82
 
Exercised
 
 
(12,357
)
 
 
22.38
 
 
 
8.63
 
Forfeited
 
 
(11,269
)
 
 
33.93
 
 
 
14.56
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance at December 31, 2020
 
 
590,047
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Granted
 
 
133,925
 
 
 
41.84
 
 
 
16.62
 
Exercised
 
 
(132,702
)
 
 
34.01
 
 
 
12.85
 
Forfeited
 
 
(11,749
)
 
 
35.79
 
 
 
15.39
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance at December 31, 2021
 
 
579,521
 
 
 
 
 
 
 
 
 
Exercisable at December 31, 2021
 
 
315,253
 
 
 
 
 
 
 
 
 
Schedule of Restricted Share Units activity
 
 
Number of
Restricted
Share Units
 
 
Weighted
average
grant date
fair value
 
 
 
 
 
 
US$
 
 
 
 
 
 
 
 

Balance at January 1, 2019

 
 
78,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vested
 
 
(39,000
)
 
 
35.36
 
 
 
 
 
 
 
 
 
 
Balance at December 31, 2019
 
 
39,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Granted
 
 
86,000
 
 
 
35.33
 
Vested
 
 
(39,000
)
 
 
34.43
 
 
 
 
 
 
 
 
 
 

Balance at December 31, 2020 and December 31, 2021

 
 
86,000
 
 
 
 
Summary of Allocation of the Stock-Based Compensation Expenses
 
 
Year ended December 31
 
 
 
2019
 
 
2020
 
 
2021
 
 
 
US$ thousands
 
 
 
 
 
 
 
 
 
 
 
Cost of sales
 
 
437
 
 
 
535
 
 
 
480
 
Research and development costs
 
 
900
 
 
 
959
 
 
 
1,011
 
Selling and marketing expenses
 
 
493
 
 
 
602
 
 
 
697
 
General and administrative expenses
 
 
525
 
 
 
615
 
 
 
674
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2,355
 
 
 
2,711
 
 
 
2,862